Journal of Heart and Lung Transplantation

Papers
(The H4-Index of Journal of Heart and Lung Transplantation is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal1214
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation317
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient charact228
A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors157
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report—2020; focus on deceased donor characterist148
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report — 2021; Focus on recipient charac137
First cases of COVID-19 in heart transplantation from China134
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response110
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry110
Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion106
Donor heart and lung procurement: A consensus statement103
Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium102
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients101
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients92
Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis86
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience77
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry75
COVID-19: Yet another coronavirus challenge in transplantation70
Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant66
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report — 2020; focus on deceased donor characteris61
Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial59
Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report58
Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation58
Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant56
Pig-to-non-human primate heart transplantation: The final step toward clinical xenotransplantation?56
Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography55
Mortality in patients with cardiogenic shock supported with VA ECMO: A systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients54
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients50
Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement49
Heart transplantation following donation after circulatory death: Expanding the donor pool48
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial47
COVID-19 vaccination in our transplant recipients: The time is now47
Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system45
International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation45
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update44
Update to an early investigation of outcomes with the new 2018 donor heart allocation system in the United States43
The impact of frailty on mortality after heart transplantation42
ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association40
Berlin Heart EXCOR and ACTION post-approval surveillance study report40
Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study39
Increased early acute cellular rejection events in hepatitis C-positive heart transplantation39
0.26795411109924